The U.S. Food and Drug Administration has approved Journey Medical's drug for the treatment of a long-term skin condition ...

Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.

Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug ...

Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosi™ ...

Journey Medical (DERM) presented data assessing the dermal and systemic pharmacokinetics of oral DFD-29 versus oral Doxycycline 40 mg capsules ...

Oct. 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq ... We submitted a New Drug Application to the U.S. Food and Drug Administration for DFD-29 earlier this year and look forward to ...

Oct. 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation ... We submitted a New Drug Application to the U.S. Food and Drug Administration for DFD-29 earlier this year and look forward ...

PhotonPharma Inc., which specializes in tumor-specific immune therapies, has hired Derek Brown as its new CEO as the company ...